Vancomycin: a history.

By D. Levine. Clinical Infectious Diseases, 2006

812 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Infectious Diseases, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/59ee8b573425d664870037327f909b3e362be800

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. B. Howden
2. T. Stinear

Citations in the corpus

• Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence (2019, background): “A couple of decades later, in 1979, coagulase-negative staphylococci resistant to vancomycin were reported and ten years later resistance in enterococci was described (Courvalin 2006), followed by, in 1997, the report of less-susceptible S. aureus (vancomycin-intermediate S. aureus, VISA) strains in”
• Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications (2010, background): “Food and Drug Administration in 1958 (178).”